AQR Capital Management - BIOSPECIFICS TECHNOLOGIES CO ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$3,974,000
-42.6%
75,230
-33.4%
0.01%
-36.4%
Q2 2020$6,922,000
-8.5%
112,950
-15.5%
0.01%
-15.4%
Q1 2020$7,564,000
-14.4%
133,702
-13.8%
0.01%
+30.0%
Q4 2019$8,833,000
+2.4%
155,136
-3.8%
0.01%0.0%
Q3 2019$8,628,000
+27.1%
161,217
+41.8%
0.01%
+25.0%
Q2 2019$6,791,000
+76.9%
113,730
+84.7%
0.01%
+100.0%
Q1 2019$3,838,000
+33.6%
61,583
+29.9%
0.00%
+33.3%
Q4 2018$2,873,000
+12.3%
47,408
+8.4%
0.00%
+50.0%
Q3 2018$2,558,000
-42.8%
43,727
-56.1%
0.00%
-60.0%
Q2 2018$4,473,000
-11.8%
99,715
-12.8%
0.01%0.0%
Q1 2018$5,071,000
-13.6%
114,376
-15.6%
0.01%
-16.7%
Q4 2017$5,871,000
+8.0%
135,493
+15.9%
0.01%0.0%
Q3 2017$5,437,000
+19.0%
116,867
+26.6%
0.01%0.0%
Q2 2017$4,570,000
+12.5%
92,305
+24.5%
0.01%
+20.0%
Q1 2017$4,064,000
+33.3%
74,159
+35.5%
0.01%
+25.0%
Q4 2016$3,048,000
+40.1%
54,722
+14.9%
0.00%
+33.3%
Q3 2016$2,175,000
+36.5%
47,632
+19.4%
0.00%0.0%
Q2 2016$1,593,000
+23.3%
39,877
+7.5%
0.00%
+50.0%
Q1 2016$1,292,000
-9.6%
37,106
+11.6%
0.00%
-33.3%
Q4 2015$1,429,000
-15.6%
33,250
-14.5%
0.00%0.0%
Q3 2015$1,693,000
+12.9%
38,897
+33.9%
0.00%0.0%
Q2 2015$1,499,000
+264.7%
29,052
+176.7%
0.00%
+200.0%
Q1 2015$411,00010,5000.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders